[HTML][HTML] COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations
Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …
significantly higher than that of the first wave of early 2020. Many countries or regions have …
[HTML][HTML] A review of the safety and efficacy of current COVID-19 vaccines
Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
[HTML][HTML] Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages
P Lee, CU Kim, SH Seo, DJ Kim - Immune network, 2021 - ncbi.nlm.nih.gov
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human
health, economy, and social life worldwide. As a counteraction for this devastating disease …
health, economy, and social life worldwide. As a counteraction for this devastating disease …
[HTML][HTML] COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response
With a death toll of over one million worldwide, the COVID-19 pandemic caused by SARS-
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
CoV-2 has become the most devastating humanitarian catastrophe in recent decades. The …
COVID-19 vaccines: concerns beyond protective efficacy and safety
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
[HTML][HTML] Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects
Z Zhang, Q Shen, H Chang - Frontiers in Immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …
[HTML][HTML] A COVID-19 vaccine: big strides come with big challenges
J Mellet, MS Pepper - Vaccines, 2021 - mdpi.com
As of 8 January 2021, there were 86,749,940 confirmed coronavirus disease 2019 (COVID-
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
19) cases and 1,890,342 COVID-19-related deaths worldwide, as reported by the World …
[HTML][HTML] COVID-19 vaccines: an updated overview of different platforms
D Kudlay, A Svistunov, O Satyshev - Bioengineering, 2022 - mdpi.com
Vaccination has been identified as a critical method of disease control in the context of the
current COVID-19 pandemic. The goal of this review is to update information on vaccine …
current COVID-19 pandemic. The goal of this review is to update information on vaccine …
[HTML][HTML] Immunological considerations for COVID-19 vaccine strategies
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …
[HTML][HTML] A narrative review of COVID-19 vaccines
B Eroglu, RF Nuwarda, I Ramzan, V Kayser - Vaccines, 2021 - mdpi.com
The COVID-19 pandemic has shaken the world since early 2020 and its health, social,
economic, and societal negative impacts at the global scale have been catastrophic. Since …
economic, and societal negative impacts at the global scale have been catastrophic. Since …